首页 | 本学科首页   官方微博 | 高级检索  
检索        

GAS/CCK-2R及其拮抗剂在胰腺癌治疗中的作用
引用本文:陈卫波,吴俊华,江春平.GAS/CCK-2R及其拮抗剂在胰腺癌治疗中的作用[J].国际外科学杂志,2010,37(9).
作者姓名:陈卫波  吴俊华  江春平
作者单位:1. 南京大学医学院,南京,210093
2. 南京大学医学院附属鼓楼医院肝胆外科,南京,210093
基金项目:南京市卫生局重点基金 
摘    要:近年来发现胃泌素/胆囊收缩素-2受体(gastrin/cholecystokinin-2 receptors,GAS/CCK-2R)与胰腺癌的发生、发展有密切关系.它在人体内广泛分布,但不存在于正常胰腺外分泌部.CCK-2R在胰腺癌组织中出现异常表达,该表达引起了胰腺外分泌部蛋白的异常表达和激活,导致腺泡细胞形态学和表型的变化,并使胰腺对致癌物质的敏感性增加.一些GAS/CCK-2R拮抗剂可用于胰腺癌的早期和晚期治疗.

关 键 词:胰腺癌  拮抗剂

GAS/CCK-2R and function of its antagonists in treatment of the pancreatic cancer
CHEN Wei-bo,WU Jun-hua,JIANG Chun-ping.GAS/CCK-2R and function of its antagonists in treatment of the pancreatic cancer[J].International Journal of Surgery,2010,37(9).
Authors:CHEN Wei-bo  WU Jun-hua  JIANG Chun-ping
Abstract:Studies in recent years revel that there is a close relationship between gastrin/cholecystokinin-2 receptors (GAS/CCK-2R) and pancreatic cancer. CCK-2R is widely distributed in human body, but not in normal exocrine pancreas. However, CCK-2R is abnormally expressed in pancreatic carcinoma. The abnormal expression of CCK-2R in pancreatic tissues leads to the abnormal protein expression and activation, changes in acinar cells' morphology and phenotype and an increase in the sensitivity to carcinogenic substances. And some GAS/CCK-2R antagonists can be used for the early and late treatment of pancreatic cancer.
Keywords:GAS/CCK-2R
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号